Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

OHIM to crack down on non-payers


Two changes affecting CTM applicants will come into effect on November 24: OHIM will only examine applications after they have been paid for, and it will also introduce a fast-track procedure

OHIM logo

The first change is driven by the desire to improve efficiency, as the Office will not spend time examining or processing mail for applications where no payment has been made.

At present, CTM applicants can pay the basic fee within one month of filing the application. About 4% of CTM applications are examined but never paid for, and OHIM says that proportion is rising.

The second change means that applications will be published in half the time it takes regular applications, or even less.

To be eligible for the fast track procedure, applicants must (1) select the goods and services from OHIM’s harmonised database and (2) pay at the end of the application process or immediately after submission. Additionally, the application should not trigger any deficiency finding at the time of submission or during examination.

More details are available on OHIM’s website.

more from across site and ros bottom lb

More from across our site

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar shares her thoughts on this year’s annual meeting in Singapore, where debates ranged from AI opportunities to improving law firm culture
The court’s ruling is a good reminder that US parties aren’t guaranteed attorney fees just because they win, say sources
With business confidence in a shaky state, Rachel Tong and Lisa Yong of Rouse discuss how in-house IP teams can manage their trademark portfolios through uncertain times
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
The US Supreme Court’s ruling wasn’t a surprise and reflects a trend that had already been bubbling away for a while, say tech and pharma counsel
Previous attempts at major transatlantic tie-ups have failed, so lawyers will keep their eyes firmly on Allen & Overy’s grand plans
INTA CEO Etienne Sanz de Acedo shares his plans if he were to win the EUIPO leadership race and says his application does not affect his INTA role
The French finance minister told António Campinos the timing of an EPO event in Lisbon could be seen as interference in the EUIPO leadership race